Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...
Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.
A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...
The tuberculosis outbreak in the Kansas City area is not, in fact, the largest in U.S. history. But it does offer an ...
The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...
Symptoms of TB include a persistent cough, chest pain, fatigue, weight loss, and fever. Since 2024, Kansas has been dealing with an outbreak of tuberculosis which has included 67 active cases and ...
Tuberculosis (TB) has long been recognized as a disease of poverty, yet most TB research does not measure poverty in a ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
Now a museum, the Saranac Laboratory was established in 1894 and was the first in the United States dedicated to studying tuberculosis.
Researchers from Australia have developed a groundbreaking mRNA vaccine against tuberculosis (TB), showing promising results in pre-clinical mouse trials. This innovative vaccine could outperform the ...
India's TB-Mukt Bharat Abhiyan has notified over 5.1 lakh TB patients, using innovative strategies like portable X-rays and NAAT testing. Over 38 lakh people have been screened, with significant ...
But the relative size of the outbreak is irrelevant. Kansas numbers continue to grow, and Dr. William Schaffner, infectious ...